- Is HBsAg Loss an Ideal End-point of Oral Antiviral Therapy in Chronic Hepatitis B Patients?
-
Kang K, Kim JH
- KMID: 2155334
- Korean J Gastroenterol.
- 2014 May;63(5):329-332.
- doi: 10.4166/kjg.2014.63.5.329
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Significance of Serum CA 125 in Patients with Chronic Liver Diseases
-
Kim YS, Kim DY, Ryu KH, Song JH, Kim MS, Jung HS, Park JY, Jung HK, Yoo K, Moon IH, Baek JY
- KMID: 1112192
- Korean J Gastroenterol.
- 2003 Nov;42(5):409-414.
BACKGROUND/AIMS: The clinical significance of serum CA 125 levels in patients with chronic liver disease has not been widely appreciated in relation to the severity of the disease. We... -
- CITED
-
- Close
- SHARE
-
- Close
- Potential Serum Markers for Monitoring the Progression of Hepatitis B Virus-Associated Chronic Hepatic Lesions to Liver Cirrhosis
-
Wu C, Liu L, Zhao P, Tang D, Yao D, Zhu L, Wang Z
- KMID: 2234074
- Gut Liver.
- 2015 Sep;9(5):665-671.
- doi: 10.5009/gnl14212
BACKGROUND/AIMS: To screen for serum protein/peptide biomarkers of hepatitis B virus (HBV)-associated chronic hepatic lesions in an attempt to profile the progression of HBV-associated chronic hepatic lesions using surface-enhanced laser... -
- CITED
-
- Close
- SHARE
-
- Close
